C2 Therapeutics
Latest round
- Series B
Last raised
- Mar 2012
Total raised
- $2.4M
Investors
- 1
About C2 Therapeutics
Based in the US, C2 Therapeutics develops ablation therapies to treat diseases of the gastrointestinal tract.
Who invested in C2 Therapeutics
1 investor across 1 round
See all investors in C2 Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Mar 31, 2012
Amount
$2.4M
Investors
Questions about C2 Therapeutics
Who invested in C2 Therapeutics?
C2 Therapeutics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has C2 Therapeutics raised?
C2 Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did C2 Therapeutics last raise money?
C2 Therapeutics's most recent round on record is a Series B, in Mar 2012.
What does C2 Therapeutics do?
Based in the US, C2 Therapeutics develops ablation therapies to treat diseases of the gastrointestinal tract.
Where is C2 Therapeutics headquartered?
C2 Therapeutics is headquartered in Redwood City, US.
Which VCs invest in companies like C2 Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at C2 Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like C2 Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.